About Academician Jing Zaiping
Academician Jing Zaiping (景在平) is a Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, and one of the most celebrated and historically significant figures in the history of vascular surgery in China. Based at the Department of Vascular Surgery, Changhai Hospital, Naval Medical University (Second Military Medical University) — the department he founded and built into one of China's foremost vascular surgery programs — Academician Jing is internationally recognized as the founding father of modern vascular surgery in China, a pioneer of endovascular aortic repair in Asia, and the surgeon whose decades of clinical innovation and research transformed the diagnosis and treatment of vascular disease across China and contributed to the global development of endovascular techniques.
When Academician Jing began his vascular surgery career at Changhai Hospital in the 1980s, vascular surgery in China was in its infancy. Open surgical repair of aortic aneurysms carried enormous mortality, peripheral arterial disease was frequently managed by amputation rather than revascularization, and endovascular techniques — which would transform the field over the following decades — were unknown in China. Academician Jing's vision was to build a vascular surgery program at Changhai Hospital that could match the best in the world — and to develop and disseminate the techniques, training, and institutional infrastructure needed to bring modern vascular surgery to patients across China. Over four decades, he achieved this vision and more: building Changhai Hospital's vascular surgery department into a national center of excellence, performing China's first endovascular aortic aneurysm repair (EVAR), pioneering the development and clinical application of domestically manufactured endovascular stent grafts, training generations of China's leading vascular surgeons, and producing a body of clinical and research work that has shaped vascular surgery practice across China and contributed to the international literature.
While Academician Jing has largely transitioned from active surgical practice, his legacy is embodied in the world-class vascular surgery program at Changhai Hospital — now one of China's highest-volume and most technically advanced vascular surgery centers — and consultations arranged through CMCS connect international patients with the program he built, the colleagues he trained, and the institutional expertise he created over four decades of dedicated work.
Hospital Affiliation: Department of Vascular Surgery, Changhai Hospital
Changhai Hospital (长海医霂), affiliated with Naval Medical University, is one of Shanghai's largest and most prestigious academic medical centers. Its Department of Vascular Surgery — founded by Academician Jing Zaiping — is one of China's most distinguished and highest-volume vascular surgery programs, performing thousands of open and endovascular vascular procedures annually. The department is equipped with a dedicated hybrid operating theater combining a fully equipped surgical suite with a fixed-installation flat-panel angiography system for complex hybrid open-endovascular procedures, an endovascular suite supporting the full range of peripheral and aortic endovascular interventions, and a vascular laboratory for non-invasive vascular assessment including duplex ultrasound, ankle-brachial index (ABI) measurement, and transcutaneous oxygen tension (TcPO2) measurement.
The department's endovascular program — built on the foundation laid by Academician Jing's pioneering work — is one of the most active in China, with particular expertise in complex aortic endovascular repair including fenestrated EVAR (FEVAR) and branched EVAR (BEVAR) for juxtarenal and thoracoabdominal aneurysms, hybrid arch reconstruction for aortic arch disease, and TEVAR for type B aortic dissection. The department maintains active research collaborations with vascular surgery centers across China and internationally, and participates in national and international registries and clinical trials of novel endovascular devices and techniques.
The Jing Zaiping Legacy: What It Means for International Patients
- Aortic aneurysm — EVAR for infrarenal AAA; TEVAR for descending thoracic aortic aneurysm; FEVAR and BEVAR for juxtarenal, pararenal, and thoracoabdominal aneurysms; hybrid arch reconstruction for aortic arch aneurysm; open surgical repair for patients not suitable for endovascular approach; the department's unmatched experience in complex aortic endovascular repair — built on Academician Jing's pioneering work — is a particular institutional strength
- Aortic dissection — TEVAR for acute and chronic complicated type B aortic dissection; medical management and surveillance for uncomplicated type B dissection; management of chronic post-dissection aneurysm; hybrid and open surgical repair for complex arch and descending aortic involvement
- Peripheral arterial disease — endovascular treatment of femoropopliteal and tibial arterial occlusive disease; open surgical bypass for complex multilevel disease; hybrid procedures; critical limb ischemia management and amputation prevention
- Carotid artery disease — carotid endarterectomy (CEA) and carotid artery stenting (CAS) for symptomatic and asymptomatic carotid stenosis; stroke prevention coordination with neurology
- Venous disease — endovenous ablation for varicose veins; DVT management including catheter-directed thrombolysis; IVC filter placement and retrieval; May-Thurner syndrome treatment
- Expert second opinion on vascular surgical management — review of vascular imaging and treatment records for patients seeking a second opinion on aortic aneurysm management, endovascular feasibility, or peripheral revascularization strategy; written English-language second opinion reports available through CMCS
Academic Legacy & Global Recognition
Academician Jing Zaiping's scientific and clinical legacy is among the most celebrated in the history of Chinese surgery. He performed China's first endovascular aortic aneurysm repair (EVAR) and was instrumental in the development and clinical validation of domestically manufactured endovascular stent grafts — a contribution that made endovascular aortic repair accessible to patients across China at a fraction of the cost of imported devices. His research program at Changhai Hospital produced foundational studies on EVAR outcomes, endovascular treatment of aortic dissection, and the development of novel endovascular techniques that have been published in leading international vascular surgery journals and cited extensively in international guidelines and systematic reviews.
Academician Jing has trained more than 200 vascular surgery fellows and residents who now lead programs across China, and his intellectual legacy is embodied in the Changhai Hospital vascular surgery department — now one of China's foremost vascular surgery programs — and in the national vascular surgery community that his work helped to create and inspire. His election to the Chinese Academy of Engineering reflects the transformative impact of his research and clinical leadership on the management of vascular disease in China.
Why International Patients Come to Changhai Hospital's Vascular Surgery Program
For international patients with aortic aneurysm, aortic dissection, peripheral arterial disease, or carotid artery disease, Changhai Hospital's vascular surgery department — built by Academician Jing Zaiping into one of China's foremost vascular surgery programs — offers a combination of clinical experience, technical expertise, endovascular innovation, and institutional infrastructure that places it among the leading vascular surgery centers in Asia.
The department's particular strengths — its unmatched experience in complex aortic endovascular repair including FEVAR and BEVAR, its hybrid operating theater capability for combined open-endovascular procedures, and its high-volume peripheral arterial disease program — make it an especially valuable resource for patients with complex aortic anatomy not suitable for standard EVAR, patients who have been told that open surgery is their only option for juxtarenal or thoracoabdominal aneurysm, and patients with critical limb ischemia requiring complex multilevel revascularization. Treatment costs at Changhai Hospital are substantially lower than equivalent care in Western healthcare systems, and access to specialist consultation is typically achievable within days through CMCS.
What to Expect at Your Consultation
Consultations at Changhai Hospital's vascular surgery department arranged through CMCS begin with a comprehensive review of all prior vascular imaging — including CT angiography of the aorta and peripheral vessels, duplex ultrasound reports, MR angiography, and prior angiography reports — relevant laboratory investigations, prior vascular surgical or endovascular intervention records, and the patient's vascular symptom history and cardiovascular risk factor profile. CMCS will arrange certified translation of all medical records and imaging reports in advance of the consultation. The consulting vascular surgeon will assess the vascular pathology, evaluate open and endovascular treatment options, outline the recommended strategy with detailed rationale, and provide a realistic assessment of expected outcomes. A written English-language consultation summary is provided after every appointment, and CMCS will facilitate direct communication between the vascular surgery team and the patient's home physicians for continuity of care.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides comprehensive end-to-end support for international patients seeking vascular surgery consultation at Changhai Hospital's Department of Vascular Surgery — the program founded by Academician Jing Zaiping. Our services include priority consultation scheduling, certified medical record and vascular imaging report translation, coordination of additional vascular imaging where required, on-site interpretation, surgical and endovascular procedure logistics, and written English-language reporting of all findings and recommendations.
📧 contract@medicalsh.com | 💬 WeChat: gezhanglao | 🌐 medicalsh.com
0 条评论